ADVFN ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Premium IconPremium Help Menu
CAC 40
8 410,39
0,31%
Dow Jones
51 671,03
0,92%
DAX
24 917,44
0,06%
Brent Oil
82,175
-0,51%
Bitcoin
66 394,19
0,17%
Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. American Exceptionalism Acquisition Corp A (AEXA)

  7. American Exceptionalism Acquisition Corp A (AEXA) Options

American Exceptionalism Acquisition Corp A

American Exceptionalism Acquisition Corp A (AEXA)

NYSE
11,26
0,00
(0,00%)
Fermé 16 Juin 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

American Exceptionalism Acquisition Corp A ([symbol]) Options

AEXA Flux des options

Achats

StrikeAchatVenteDernier PrixPoint MédianVarVar %VolumeINT OUVERTDernière Trans
2,506,7010,800,008,750,000,00 %00-
5,004,208,300,006,250,000,00 %00-
6,003,207,300,005,250,000,00 %00-
7,501,705,800,003,750,000,00 %00-
9,000,904,303,072,600,000,00 %010-
10,000,053,301,201,6750,000,00 %04 829-
11,000,201,500,400,850,000,00 %53 66015/6/2026
12,500,050,100,050,075-0,02-28,57 %1011 96415/6/2026
14,000,002,150,050,050,000,00 %01-
15,000,050,350,050,200,000,00 %172115/6/2026
16,000,002,150,000,000,000,00 %00-
17,500,002,150,060,060,000,00 %0117-
19,000,002,150,200,200,000,00 %04-
20,000,000,100,050,050,000,00 %03 726-

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Ventes

StrikeAchatVenteDernier PrixPoint MédianVarVar %VolumeINT OUVERTDernière Trans
2,500,002,150,000,000,000,00 %00-
5,000,002,150,050,050,000,00 %2015/6/2026
6,000,002,150,000,000,000,00 %00-
7,500,002,151,031,030,000,00 %031-
9,000,002,150,000,000,000,00 %00-
10,000,000,051,131,130,000,00 %031-
11,000,002,250,200,200,000,00 %020-
12,500,053,302,801,6750,000,00 %01-
14,000,704,800,002,750,000,00 %00-
15,001,705,800,003,750,000,00 %00-
16,002,656,800,004,7250,000,00 %00-
17,504,208,300,006,250,000,00 %00-
19,005,709,800,007,750,000,00 %00-
20,006,7010,800,008,750,000,00 %00-

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AACIUArmada Acquisition Corporation III
US$ 10,30
(0,00%)
0
AACIArmada Acquisition Corporation III
US$ 9,96
(0,00%)
0
AACGATA Creativity Global
US$ 1,01
(0,00%)
0
AACBUArtius II Acquisition Inc
US$ 10,61
(0,00%)
0
AACBArtius II Acquisition Inc
US$ 10,51
(0,00%)
0
AACIUArmada Acquisition Corporation III
US$ 10,30
(0,00%)
0
AACIArmada Acquisition Corporation III
US$ 9,96
(0,00%)
0
AACGATA Creativity Global
US$ 1,01
(0,00%)
0
AACBUArtius II Acquisition Inc
US$ 10,61
(0,00%)
0
AACBArtius II Acquisition Inc
US$ 10,51
(0,00%)
0
AACIUArmada Acquisition Corporation III
US$ 10,30
(0,00%)
0
AACIArmada Acquisition Corporation III
US$ 9,96
(0,00%)
0
AACGATA Creativity Global
US$ 1,01
(0,00%)
0
AACBUArtius II Acquisition Inc
US$ 10,61
(0,00%)
0
AACBArtius II Acquisition Inc
US$ 10,51
(0,00%)
0

Discussion

Afficher le flux complet
CelestialSage6 CelestialSage6 il y a 10 minutes
Yes, I understand. Even if you combine all of that, can it beat Dupixent? Alteogen only collaborates with the best companies. On the other hand, Halozyme has signed contracts with companies that I don't even know if they are actually working with. So, it's not Alteogen signing with junk, but Halozym
HALO
CA Market News CA Market News il y a 11 minutes
Herbal Dispatch Provides Update on Domestic Retail Operations and Proprietary Brand ExpansionJune 16, 2026 3:01 AM
NewsfileVancouver, B
LUFFF
tkg tkg il y a 16 minutes
The Strategic Verdict

This Forbes article is a massive structural validation for long-term Lightwave shareholders. For years, the bears argued that Lightwave was a standalone science project trying to force its way into the market.

Now, the U.S. government and GlobalFou
LWLG
Hellie Hellie il y a 19 minutes
11/06 , maybe you're right!
LWLG
biotechinvestor1 biotechinvestor1 il y a 21 minutes
Here are a few of those drugs:
Ebglyss (IL-13)Adbry (IL-13)Nemluvio (IL-31 receptor)Late-stage agents such as zumilokibart. 
HALO
Henk van vleuten Henk van vleuten il y a 23 minutes
When was it publiced? Maybe this why on 12june there was a huge spike on Jan 2027 15 options??
LWLG
biotechinvestor1 biotechinvestor1 il y a 24 minutes
You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs:
HALO
God Bless America God Bless America il y a 25 minutes
Of course they did not buy because they knew the regulation. Their families did buy instead.
FNMA
US Market News US Market News il y a 25 minutes
Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2026June 16, 2026 3:00 AM
PR Newswire (US) class="legendSpanClass"BEIJING, class="legendSpanClass"June 16, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company
UXIN
US Market News US Market News il y a 25 minutes
DXC Expands Relationship with Norske Skog to Modernize Network and Technology OperationsJune 16, 2026 3:00 AM
PR Newswire (US) Multi-year partnership delivers a modern, secure network solution while broadening DXC's role across Norske Sko
DXC
US Market News US Market News il y a 25 minutes
Solidion Technology Announced AI-Assisted Design and Manufacturing Technology of Bipolar Solid-State Batteries for Space Vehicles, Ground, Sea, Air and InfrastructureJune 16, 2026 3:00 AM
PR Newswire (US) The company's revolutionary, pate
STI
US Market News US Market News il y a 26 minutes
Elite Tech, Accessible Price - Introducing the Logitech G3 Series Mouse and Keyboard for PC GamingJune 16, 2026 3:05 AM
Business Wire Elite Precision - Unleash pro-grade speed with the G305 X SUPERLIGHT gaming mouse and G316 X 98 gaming keyboard. Featur
LOGI
biotechinvestor1 biotechinvestor1 il y a 28 minutes
You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs:
Late-stage agents such as zumilokibar
HALO
US Market News US Market News il y a 41 minutes
Unilever Scales Digital Twins Across Global Manufacturing Network with AccentureJune 16, 2026 2:59 AM
Business WireUnilever (LON: ULVR) is partnering with Accenture (NYSE: ACN) to scale the use of AI-enabled digital twins across its global manufacturing network
ACN
CelestialSage6 CelestialSage6 il y a 43 minutes
You can't refute it. Yes, I understand your level well.
HALO
biotechinvestor1 biotechinvestor1 il y a 49 minutes
Total nonsense! I have no interest in educating you.
HALO
Nemesis18 Nemesis18 il y a 50 minutes
She'll probably move to somewhere without any extradition treaty once the plug is finally pulled on this 'cancer vaccine' scam.?
NWBO
price_and_volume price_and_volume il y a 52 minutes
Gonna have to bump the A/S then...
He said recently that they are looking at another acquisition...and he will dilute with shares to get it. Agreed - I posted the same, "where's the finance coming from for acquisitions?"...

Supposed 400MM shares going to $GTVH (believe it when
SNTX
StockItOut StockItOut il y a 53 minutes
WKSP Weekly chart: https://schrts.co/IIIuZpgy
WKSP
CelestialSage6 CelestialSage6 il y a 54 minutes
I understand that Halozyme has not signed any exclusive agreements regarding treatments or indications related to Dupixent, so why is Sanofi collaborating with Alteogen?

Also, Halozyme's mdase patent is being invalidated due to Merck. Alteogen's technology is more advanced than Halozy
HALO
Wolf-man jack Wolf-man jack il y a 55 minutes
WQLF SAYS: Have Mercy WQLF ahoooooo

Q: Why hasn't CV SCIENCES been accepted in the CMS Medicare Pilot Program?

Ai Generated:

C V Sciences has not been "accepted" into the CMS Medicare Pilot Program because the pilot is a provider-led incentive, not a
CVSI
price_and_volume price_and_volume il y a 57 minutes
What reasonable expectation is there of PPS responding?
whether management can successfully execute on the vision they have laid out. Nobody cares about "the company" or "the management" or "their vision" or your two-bit-MBA-tutorials-in-a-post.

Enough of all that garbage.
RWAX
mrwrn2010 mrwrn2010 il y a 60 minutes
Disagree. The outcome of OxyContin litigation was unknown 9 months to a year ago. You can guess at a variety of outcomes, sure, but it’s not certain. Same thing with human trials - we don’t have positive trial results for anything in the pipeline until we have them. What passes in vitro may not pass
ELTP
PEACHMAN PEACHMAN il y a 1 heure
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177680761


IFUS STRONG
IFUS

Dernières Valeurs Consultées

NYSE
AEXA
American Exceptionalism ...
USOTC
WYNMY
Wynn Macau (PK)
NYSE
ATH-A
Athene
USOTC
SHIEF
Shield Therapeutics (QB)
LSE
FJUL
First Trust Vest US Equi...
TG
KSX
KnightSwift Transportation
LSE
0MWP
Coinshares XBT Provider AB
LSE
FL84
7.950% Nts 26/04/28
USOTC
PNNX
Pennexx Foods (ID)
TSXV
XCYT
Xcyte Digital
USOTC
KLPEF
Klepierre (PK)
CSE
MJRX
Global Health Clinics
AMEX
PMJN
PGIM S&P 500 Max Buffer ...
ASX
CHMO
Chimeric Therapeutics
LSE
36EL
Glaxosmsc4.00%
NYSE
PCEB
FundVantage Trus
Delayed Upgrade Clock
ADVFN
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2026 ADVFN Ltd - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces